192 related articles for article (PubMed ID: 11659482)
1. You read it first here!
Crigger BJ
IRB; 1992; 14(5):10-1. PubMed ID: 11659482
[No Abstract] [Full Text] [Related]
2. Ethics lobby forces rethink on growth hormones.
Miller SK
New Sci; 1992 Aug; 135(1834):9. PubMed ID: 11659508
[No Abstract] [Full Text] [Related]
3. The NIH trials of growth hormone for short stature.
Tauer CA
IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923
[No Abstract] [Full Text] [Related]
4. Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone?
Prentice ED; Antonson DL; Jameton A; Graber B; Sears T
IRB; 1989; 11(1):6-10. PubMed ID: 11659085
[No Abstract] [Full Text] [Related]
5. Half-full or half-empty? Evaluating IRB performance.
Mishkin B; Ariand N
Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
[No Abstract] [Full Text] [Related]
6. The regulation of human experimentation in the United States--a personal odyssey.
Katz J
IRB; 1987; 9(1):1-6. PubMed ID: 11649890
[No Abstract] [Full Text] [Related]
7. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
8. Ethical issues in clinical neurological research.
Shore D; Berg K; Mullican C
J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
[No Abstract] [Full Text] [Related]
9. Government guinea pigs.
Rothman DJ
N Y Times Web; 1994 Jan; ():E21. PubMed ID: 11646304
[No Abstract] [Full Text] [Related]
10. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
11. Research compliance changes will affect rules on protection of human subjects.
Maloney DM
Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
[No Abstract] [Full Text] [Related]
12. Human Gene Therapy Subcommittee: minutes of meeting, 29-30 Jul 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee
Hum Gene Ther; 1992 Aug; 3(4):439-55. PubMed ID: 11643020
[No Abstract] [Full Text] [Related]
13. Exempt research: procedures in the intramural research program of the National Institutes of Health.
Wichman A; Mills D; Sandler AL
IRB; 1996; 18(2):3-5. PubMed ID: 11654755
[No Abstract] [Full Text] [Related]
14. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
15. Minutes of meetings, 31 Jul 1990 16 Oct 1990.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1991; 2(2):177-91. PubMed ID: 11642903
[No Abstract] [Full Text] [Related]
16. Federal report says protection of human subjects is threatened by numerous factors.
Maloney DM
Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
[No Abstract] [Full Text] [Related]
17. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
18. All is not well in research on human subjects.
Goldman J
N Y Times Web; 1986 Mar; ():A26. PubMed ID: 11647822
[No Abstract] [Full Text] [Related]
19. The quality of mercy.
Crigger BJ
Hastings Cent Rep; 1993; 23(3):3. PubMed ID: 11643129
[No Abstract] [Full Text] [Related]
20. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
Gordon VM; Sugarman J; Kass N
IRB; 1998; 20(1):1-5. PubMed ID: 11655324
[No Abstract] [Full Text] [Related]
[Next] [New Search]